会议专题

Comparative Study the Antiplatelet Function of Clopidogrel by Verifynow Antiplatelet Treatment Monitor System ,Light Transmission Aggregometry and Platelet Membrane Glucoprotein Molecule Tested by Flow Cytometry

  Objective:To use Verifynow antiplatelet treatment monitor system(Verifynow), light transmission aggregometry(LTA) and PAC-1, CD62p tested by flow cytometry(FC) to study comparatively the antiplatelet function of clopidogrel.Method:①To draw 3ml blood samples of 71 patients who were selected from the inpatients or outpatients with acute coronary syndrome from 2011 March to 2011 July before they were treated and after that with two 3.8% sodium citrate anticoagulation vacutainers; We took out of 5μL blending whole blood from one of the two 3 ml samples to test the activity index of PAC-1 and CD62p by FC.

Verifynow LTA Platelet aggregation PAC-1 CD62p

REN Junwei Chen Jiankui Cong Yulong Bai Jie Li Yuru Wang Yina

Department of clinical laboratory,NO.307 Hospital of PLA,Beijing,100161,China Department of clinical laboratory,The South Tower Of The PLA General Hospital,Beijing,100853,China

国内会议

2012北京检验医学年会暨中青年检验医学论坛

北京

英文

2-7

2012-10-01(万方平台首次上网日期,不代表论文的发表时间)